Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) gapped down prior to trading on Wednesday . The stock had previously closed at $30.09, but opened at $28.50. Mirum Pharmaceuticals shares last traded at $28.65, with a volume of 109,835 shares traded. Analyst Upgrades and Downgrades MIRM has been the topic of a number of research reports. […]
NEA Management Company LLC reduced its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) by 0.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,186,243 shares of the company’s stock after selling 1,558 shares during the quarter. Mirum Pharmaceuticals […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) – SVB Leerink issued their FY2025 earnings per share estimates for Mirum Pharmaceuticals in a research note issued to investors on Thursday, May 4th. SVB Leerink analyst M. Foroohar anticipates that the company will post earnings per share of $1.93 for the year. SVB Leerink has a “Outperform” […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) Director Michael G. Grey sold 14,608 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $28.00, for a total value of $409,024.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Rating) will be issuing its quarterly earnings data after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.96) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. Mirum Pharmaceuticals […]